10.1.3 Drugs that suppress the rheumatic disease process
Abatacept
Orencia 125mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Orencia 250mg powder for concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Orencia 50mg/0.4ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Orencia 87.5mg/0.7ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Orencia ClickJect 125mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Adalimumab
Amgevita 20mg/0.2ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Amgevita 20mg/0.4ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Amgevita 40mg/0.4ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Amgevita 40mg/0.4ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Amgevita 40mg/0.8ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Amgevita 40mg/0.8ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Amgevita 80mg/0.8ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Amgevita 80mg/0.8ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Imraldi 40mg/0.8ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Imraldi 40mg/0.8ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Anakinra
Kineret 100mg/0.67ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Still's disease |
Apremilast
Otezla 10mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Otezla 20mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Otezla 30mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Azathioprine
Azathioprine 25mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Respiratory system | Interstitial Lung Disease |
Azathioprine 50mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Respiratory system | Interstitial Lung Disease |
Baricitinib
Baricitinib 2mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Baricitinib 4mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Belimumab
Belimumab 120mg powder for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
Belimumab 200mg/1ml solution for injection pre-filled disposable devices
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
Belimumab 400mg powder for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
Certolizumab pegol
Certolizumab pegol 200mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Ciclosporin
Capimune 100mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Capimune 25mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Capimune 50mg capsules
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Neoral 100mg/ml oral solution
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Cyclophosphamide
Cyclophosphamide 1g powder for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
Cyclophosphamide 2g powder for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
Cyclophosphamide 500mg powder for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
Cyclophosphamide 50mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Etanercept
Benepali 50mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Benepali 50mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Enbrel 25mg powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Enbrel 25mg/0.5ml solution for injection pre-filled MyClic pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Enbrel 25mg/0.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Enbrel Paediatric 10mg powder and solvent for solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Filgotinib
Jyseleca 100mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Jyseleca 200mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Golimumab
Simponi 50mg/0.5ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Simponi 50mg/0.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Guselkumab
Tremfya 100mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Hydroxychloroquine
Hydroxychloroquine 200mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Hydroxychloroquine 300mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Infliximab
Remsima 100mg powder for concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Remsima 120mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Ixekizumab
Taltz 80mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Taltz 80mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Leflunomide
Leflunomide 10mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Leflunomide 20mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Methotrexate
Methotrexate 10mg/5ml oral solution
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Methotrexate 10mg/5ml oral suspension
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
Methotrexate 2.5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 10mg/0.2ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 12.5mg/0.25ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 15mg/0.3ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 17.5mg/0.35ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 20mg/0.4ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 22.5mg/0.45ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 25mg/0.5ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Respiratory system | Interstitial Lung Disease |
Metoject PEN 7.5mg/0.15ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Respiratory system | Interstitial Lung Disease |
Mycophenolate mofetil
Mycophenolate mofetil 500mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Eye | Uveitis |
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Respiratory system | Interstitial Lung Disease |
Rituximab
Ruxience 100mg/10ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Ruxience 500mg/50ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Systemic lupus erythematosus |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Sarilumab
Kevzara 150mg/1.14ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Kevzara 200mg/1.14ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Kevzara 200mg/1.14ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
Secukinumab
Cosentyx 150mg/1ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Cosentyx 150mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Cosentyx 300mg/2ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Cosentyx 75mg/0.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Secukinumab 150mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Secukinumab 300mg/2ml solution for injection pre-filled disposable devices
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Sulfasalazine
Sulfasalazine 250mg/5ml oral suspension sugar free
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Sulfasalazine 500mg gastro-resistant tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Specialist Paediatric Rheumatology Management |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Tocilizumab
Tyenne 162mg/0.9ml solution for injection pre-filled pens
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Giant Cell Arteritis |
| Musculoskeletal and joint diseases | Still's disease |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Tyenne 162mg/0.9ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Giant Cell Arteritis |
| Musculoskeletal and joint diseases | Still's disease |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Tyenne 200mg/10ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Still's disease |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Tyenne 400mg/20ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Still's disease |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Tyenne 80mg/4ml concentrate for solution for infusion vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Still's disease |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Tofacitinib
Xeljanz 1mg/ml oral solution
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Xeljanz 5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Juvenile Idiopathic Arthritis (JIA) |
Upadacitinib
Rinvoq 15mg modified-release tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
| Musculoskeletal and joint diseases | Rheumatoid Arthritis |
| Musculoskeletal and joint diseases | Axial Spondyloarthritis |
Ustekinumab
Pyzchiva 45mg/0.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Pyzchiva 90mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Wezenla 45mg/0.5ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Wezenla 45mg/0.5ml solution for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |
Wezenla 90mg/1ml solution for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Gastro-intestinal system | Crohn’s disease |
| Musculoskeletal and joint diseases | Psoriatic Arthritis |